Allergan Plc Aug. 24 said it is voluntarily recalling lots of certain eye drugs, including Refresh Lacri-Lube, Refresh P.M., FML (fluorometholone ophthalmic ointment) and Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment).
Refresh Lacri-Lube and Refresh P.M. are used to treat dry eyes, FML is used to treat inflammation of the eyes and eyelids, and Blephamide is used to treat or prevent eye infections.
The Dublin-based company said it chose to initiate this recall based on a small number of customer complaints about a small black particle at the time of use. This black particle, which is part of the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.